实践表明,慢性迁延性肝炎(慢迁肝,CPH)与慢性活动性肝炎(慢活肝,CAH),甚至慢性和急性肝炎仅凭临床表现难以准确鉴别,但其治疗重点及转归却殊有不同。本文意在通过临床、病原免疫学及病理学诸方面资料的综合分析,力求对发病率较高及颇为引人关 Practice shows that chronic persistent hepatitis (slow-moving liver, CPH) and chronic active hepatitis (slow-living liver, CAH), and even chronic and acute hepatitis, clinical manifestations alone can not accurately identify, but the treatment focus and prognosis are unique different. This article is intended by clinical, pathogenic immunology and pathology in a comprehensive analysis of various aspects of data, to seek a higher incidence and quite attractive